Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 28Neoplasms 13Colonic Neoplasms 12Breast Neoplasms 12Prostatic Neoplasms 9Polycythemia Vera 9Venous Thromboembolism 8Multiple Myeloma 8Recurrence 6Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 5Thrombocythemia, Essential 4Ovarian Neoplasms 4Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Myeloproliferative Disorders 4Esophageal Neoplasms 4Cardiovascular Diseases 4Barrett Esophagus 4Stomach Neoplasms 3Precancerous Conditions 3Melanoma 3Lung Neoplasms 3Gastrointestinal Neoplasms 3Adenomatous Polyps 3Adenoma 3Tobacco Use Disorder 2Thrombosis 2Thromboembolism 2Smoking Cessation 2

Interventions

Zoledronic Acid 4Denosumab 4Toremifene 2Aromatase Inhibitors 2radium Ra 223 dichloride 1Vitamin D 1Tobacco Products 1Propofol 1Neuroleptanalgesia 1Midazolam 1Letrozole 1Hormone Replacement Therapy 1Heart Disease Risk Factors 1Exercise 1Etomidate 1Ethanol 1Cholecalciferol 1Cari-D-Tect 1Aspirin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fractures, Bone × Aspirin × Clear all
NCT01646437 2021-09-16

TIPS-3

Population Health Research Institute

Phase 3 Completed
7,793 enrolled

Cardiovascular Diseases, Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡